UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000016584
Receipt No. R000019240
Official scientific title of the study Combination of revascularization surgery and double filtration plasmapheresis with thermo-recirculation (DF Thermo) for the treatment of peripheral arterial disease (ASO)
Date of disclosure of the study information 2015/02/20
Last modified on 2017/12/23 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Combination of revascularization surgery and double filtration plasmapheresis with thermo-recirculation (DF Thermo) for the treatment of peripheral arterial disease (ASO)
Title of the study (Brief title) Combination of revascularization surgery and double filtration plasmapheresis with thermo-recirculation (DF Thermo) for the treatment of peripheral arterial disease (ASO)
Region
Japan

Condition
Condition Peripheral arterial disease with wound and/or ulcer in the lower limb
Classification by specialty
Plastic surgery
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the efficacy of DF Thermo therapy in the severe ischemic limb ASO patients who underwent bypass revascularization surgery, and with wound and/or ulcer in the lower limb.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Rate of diminishment of wound and/or ulcer by DF thermo therapy
Key secondary outcomes SPP, ABI, ultrasonography of lower limb, VEGF, fibrinogen, IgM, LDL-cholesterol, HDL-cholesterol, total cholesterol, DESIGN-R, Vascu QOL

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 DF Thermo group (Patients underwent DF Thermo therapy)
Study period; 35 weeks at the maximum
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
86 years-old >
Gender Male and Female
Key inclusion criteria Patients who fulfill all of the following conditions are included.
1) Age is over 20 years and less than 86 years, regardless of sex
2) Diagnosed as ASO with Fontaine Grade IV
3) With wound and/or ulcer in the lower limb and underwent bypass revascularization surgery
4) Patients who can give written informed consent by themselves or by their surrogates, understanding the objective and content of the study
Key exclusion criteria Patients who fulfill any of the following conditions are excluded.
1) Pregnancy, breast-feeding, with possibility of pregnancy, or who wish to become pregnant during the study period
2) Patients who are considered as inadequate by the physician in charge
Target sample size 12

Research contact person
Name of lead principal investigator Shinji Togashi
Organization Shonai Amarume Hospital
Division name Plastic and reconstructive surgery
Address 1-1-1 Shoyo, Shonai-town, Hogashitagawa, Yamagata
TEL 0234-43-3434
Email stoga@amarume-hp.jp

Public contact
Name of contact person Shinji Togashi
Organization Shonai Amarume Hospital
Division name Plastic and reconstructive surgery
Address 1-1-1 Shoyo, Shonai-town, Hogashitagawa, Yamagata
TEL 0234-43-3434
Homepage URL
Email stoga@amarume-hp.jp

Sponsor
Institute Shonai Amarume Hospital
Institute
Department

Funding Source
Organization Kawasumi Laboratories, Inc.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 02 Month 20 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2015 Year 01 Month 05 Day
Anticipated trial start date
2015 Year 02 Month 25 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 02 Month 19 Day
Last modified on
2017 Year 12 Month 23 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000019240